Spots Global Cancer Trial Database for Chromosomal Damage in Type 2 Diabetes Patients (MIKRODIAB)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Chromosomal Damage in Type 2 Diabetes Patients (MIKRODIAB)
Official Title: Incidence of Chromosomal Damage in Type 2 Diabetes Patients
Study ID: NCT02231736
Interventions
Study Description
Brief Summary: The purpose of the study is to determine whether glycemic control (HbA1c) is linked to chromosomal damage in type 2 Diabetes patients
Detailed Description:
Eligibility
Minimum Age: 30 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
University of Vienna, Vienna, , Austria
Contact Details
Name: Karl-Heinz Wagner, PhD
Affiliation: UNIVIE
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
